Type 2 diabetes mellitus and obesity in sub-Saharan Africa

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 6, 2010, Pages 433-445

  Tuei, Vivian C ^a,b   Maiyoh, Geoffrey K ^c   Ha, Chung Eun ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c MOI UNIVERSITY   (Kenya)

Author keywords

Care challenges; Epidemiology; Pathogenesis; Risk factors; Sub Saharan Africa; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLICLAZIDE; METFORMIN;

AFRICA; AGING; COMORBIDITY; DEMOGRAPHY; GLYCEMIC CONTROL; HEALTH CARE SYSTEM; HUMAN; IMMOBILIZATION; LIFESTYLE MODIFICATION; METABOLIC DISORDER; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIOECONOMICS; URBANIZATION;

AFRICA SOUTH OF THE SAHARA; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; RISK FACTORS;

EID: 77956627427     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1106     Document Type: Review

References (180)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14(Suppl 5): S1-S85.
2. International Diabetes Federation. Triennial Report (1991-1994) and Directory. 1994.
3. McCarty D, Zimmet P. Diabetes 1994 to 2010: Global Estimates and Projections. International Diabetes Institute: Melbourne, 1994.
4. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
5. International Diabetes Federation. Diabetes Atlas (3rd edn). International Diabetes Federation: Brussels, Belgium, 2006.
6. International Diabetes Federation. Diabetes Atlas (4th edn). International Diabetes Federation: Brussels, Belgium, 2009.
7. World Health Organization. Prevention of diabetes mellitus. Technical Report Series no. 844. World Health Organization: Geneva, 1994.
8. Campbell RK. Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. J Am Pharm Assoc (2003) 2009; 49(Suppl 1): S3-S9.
9. Adiels M, Olofsson SO, Taskinen MR, Boren J. Diabetic dyslipidaemia. Curr Opin Lipidol 2006; 17: 238-246.
10. Levitt NS. Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 2008; 94: 1376-1382.
11. de Onis M, Blossner M. Prevalence and trends of overweight among preschool children in developing countries. Am J Clin Nutr 2000; 72: 1032-1039.
12. Motala AA, Omar MA, Pirie FJ. Diabetes in Africa. Epidemiology of type 1 and type 2 diabetes in Africa. J Cardiovasc Risk 2003; 10: 77-83.
13. McLarty DG, Pollitt C, Swai AB. Diabetes in Africa. Diabet Med 1990; 7: 670-684.
14. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab 2001; 27: 628-634.
15. McLarty DG, Swai AB, Kitange HM, et al. Prevalence of diabetes and impaired glucose tolerance in rural Tanzania. Lancet 1989; 1: 871-875.
16. Aspray TJ, Mugusi F, Rashid S, et al. Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg 2000; 94: 637-644.
17. Fisch A, Pichard E, Prazuck T, Leblanc H, Sidibe Y, Brucker G. Prevalence and risk factors of diabetes mellitus in the rural region of Mali (West Africa): a practical approach. Diabetologia 1987; 30: 859-862.
18. Teuscher T, Baillod P, Rosman JB, Teuscher A. Absence of diabetes in a rural West African population with a high carbohydrate/cassava diet. Lancet 1987; 1: 765-768.
19. Ohwovoriole AE, Kuti JA, Kabiawu SI. Casual blood glucose levels and prevalence of undiscovered diabetes mellitus in Lagos metropolis Nigerians. Diabetes Res Clin Pract 1988; 4: 153-158.
20. Erasmus RT, Fakeye T, Olukoga O, et al. Prevalence of diabetes mellitus in a Nigerian population. Trans R Soc Trop Med Hyg 1989; 83: 417-418.
21. Cooper RS, Rotimi CN, Kaufman JS, et al. Prevalence of NIDDM among populations of the African diaspora. Diabetes Care 1997; 20: 343-348.
22. Mbanya JC, Ngogang J, Salah JN, Minkoulou E, Balkau B. Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in Cameroon. Diabetologia 1997; 40: 824-829.
23. Ducorps M, Baleynaud S, Mayaudon H, Castagne C, Bauduceau B. A prevalence survey of diabetes in Mauritania. Diabetes Care 1996; 19: 761-763.
24. Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S. Type 2 diabetes in adult Nigerians: a study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract 2003; 62: 177-185.
25. Mbanya JC, Cruickshank JK, Forrester T, et al. Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. Diabetes Care 1999; 22: 434-440.
26. Amoah AG, Owusu SK, Adjei S. Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res Clin Pract 2002; 56: 197-205.
27. Balde NM, Diallo I, Balde MD, et al. Diabetes and impaired fasting glucose in rural and urban populations in Futa Jallon (Guinea): prevalence and associated risk factors. Diabetes Metab 2007; 33: 114-120.
28. Ahren B, Corrigan CB. Prevalence of diabetes mellitus in north-western Tanzania. Diabetologia 1984; 26: 333-336.
29. Elbagir MN, Eltom MA, Elmahadi EM, Kadam IM, Berne C. A population-based study of the prevalence of diabetes and impaired glucose tolerance in adults in Northern Sudan. Diabetes Care 1996; 19: 1126-1128.
30. Ramaiya KL, Denver E, Yudkin JS. Diabetes, impaired glucose tolerance and cardiovascular disease risk factors in the Asian Indian Bhatia community living in Tanzania and in the United Kingdom. Diabet Med 1995; 12: 904-910.
31. Christensen DL, Friis H, Mwaniki DL, et al. Prevalence of glucose intolerance and associated risk factors in rural and urban populations of different ethnic groups in Kenya. Diabetes Res Clin Pract 2009; 84: 303-310.
32. Levitt NS, Katzenellenbogen JM, Bradshaw D, Hoffman MN, Bonnici F. The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa. Diabetes Care 1993; 16: 601-607.
33. Dowse GK, Gareeboo H, Zimmet PZ, et al. High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabetes 1990; 39: 390-396.
34. Favier F, Jaussent I, Moullec NL, et al. Prevalence of type 2 diabetes and central adiposity in La Reunion Island, the REDIA study. Diabetes Res Clin Pract 2005; 67: 234-242.
35. Omar MA, Seedat MA, Motala AA, Dyer RB, Becker P. The prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban South African blacks. S Afr Med J 1993; 83: 641-643.
36. Mollentze WF, Moore AJ, Steyn AF, et al. Coronary heart disease risk factors in a rural and urban Orange Free State black population. S Afr Med J 1995; 85: 90-96.
37. Omar MA, Seedat MA, Dyer RB, Motala AA, Knight LT, Becker PJ. South African Indians show a high prevalence of NIDDM and bimodality in plasma glucose distribution patterns. Diabetes Care 1994; 17: 70-73.
38. Omar MA, Seedat MA, Dyer RB, Rajput MC, Motala AA, Joubert SM. The prevalence of diabetes mellitus in a large group of South African Indians. S Afr Med J 1985; 67: 924-926.
39. Motala AA, Esterhuizen T, Gouws E, Pirie FJ, Omar MA. Diabetes and other disorders of glycemia in a rural South African community: prevalence and associated risk factors. Diabetes Care 2008; 31: 1783-1788.
40. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
41. Motala AA. Diabetes trends in Africa. Diabetes Metab Res Rev 2002; 18(Suppl 3): S14-S20.
42. Dagogo-Jack S. Primary prevention of type-2 diabetes in developing countries. J Natl Med Assoc 2006; 98: 415-419.
43. Elbagir MN, Eltom MA, Elmahadi EM, Kadam IM, Berne C. A high prevalence of diabetes mellitus and impaired glucose tolerance in the Danagla community in Northern Sudan. Diabet Med 1998; 15: 164-169.
44. Prentice AM, Moore SE. Early programming of adult diseases in resource poor countries. Arch Dis Child 2005; 90: 429-432.
45. Ramaiya KL, Swai AB, McLarty DG, Alberti KG. Impaired glucose tolerance and diabetes mellitus in Hindu Indian immigrants in Dar es Salaam. Diabet Med 1991; 8: 738-744.
46. Swai AB, McLarty DG, Sherrif F, et al. Diabetes and impaired glucose tolerance in an Asian community in Tanzania. Diabetes Res Clin Pract 1990; 8: 227-234.
47. Chapman AR. Globalization, human rights, and the social determinants of health. Bioethics 2009; 23: 97-111.
48. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008; 93: S9-S30.
49. Belue R, Okoror TA, Iwelunmor J, et al. An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Global Health 2009; 5: 10.
50. James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004; 11: 3-8.
51. Sharma AM, Chetty VT. Obesity, hypertension and insulin resistance. Acta Diabetol 2005; 42(Suppl 1): S3-S8.
52. van der Merwe MT, Pepper MS. Obesity in South Africa. Obes Rev 2006; 7: 315-322.
53. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 2007; 356: 213-215.
54. Martorell R, Khan LK, Hughes ML, Grummer-Strawn LM. Obesity in women from developing countries. Eur J Clin Nutr 2000; 54: 247-252.
55. Puoane T, Steyn K, Bradshaw D, et al. Obesity in South Africa: the South African demographic and health survey. Obes Res 2002; 10: 1038-1048.
56. Bray GA. Risks of obesity. Endocrinol Metab Clin North Am 2003; 32: 787-804, viii.
57. Kamadjeu RM, Edwards R, Atanga JS, Kiawi EC, Unwin N, Mbanya JC. Anthropometry measures and prevalence of obesity in the urban adult population of Cameroon: an update from the Cameroon Burden of Diabetes Baseline Survey. BMC Public Health 2006; 6: 228.
58. Osei K, Schuster DP, Amoah AG, Owusu SK. Diabetes in Africa. Pathogenesis of type 1 and type 2 diabetes mellitus in sub-Saharan Africa: implications for transitional populations. J Cardiovasc Risk 2003; 10: 85-96.
59. Fezeu L, Minkoulou E, Balkau B, et al. Association between socioeconomic status and adiposity in urban Cameroon. Int J Epidemiol 2006; 35: 105-111.
60. Christensen DL, Eis J, Hansen AW, et al. Obesity and regional fat distribution in Kenyan populations: impact of ethnicity and urbanization. Ann Hum Biol 2008; 35: 232-249.
61. Martorell R, Kettel Khan L, Hughes ML, Grummer-Strawn LM. Overweight and obesity in preschool children from developing countries. Int J Obes Relat Metab Disord 2000; 24: 959-967.
62. Kruger R, Kruger HS, Macintyre UE. The determinants of overweight and obesity among 10- to 15-year-old schoolchildren in the North West Province, South Africa - the THUSA BANA (Transition and Health during Urbanisation of South Africans; BANA, children) study. Public Health Nutr 2006; 9: 351-358.
63. Joffe B, Zimmet P. The thrifty genotype in type 2 diabetes: an unfinished symphony moving to its finale? Endocrine 1998; 9: 139-141.
64. Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes 1988; 37: 622-628.
65. Levitt NS, Lambert EV. The foetal origins of the metabolic syndrome - a South African perspective. Cardiovasc J S Afr 2002; 13: 179-180.
66. Siervo M, Grey P, Nyan OA, Prentice AM. A pilot study on body image, attractiveness and body size in Gambians living in an urban community. Eat Weight Disord 2006; 11: 100-109.
67. Karmon SL, Moore RD, Dobs AS, Keruly J, Barnett S, Cofrancesco J Jr. Body shape and composition in HIV-infected women: an urban cohort. HIV Med 2005; 6: 245-252.
68. Joost H-G. Pathogenesis, risk assessment and prevention of type 2 diabetes mellitus. Obesity Facts 2008; 1: 128-137.
69. Napoli N, Mottini G, Arigliani M, et al. Unexpectedly high rates of obesity and dysglycemia among villagers in Cameroon. Diabetes Metab Res Rev 2010; 26: 10-12.
70. Popkin BM. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr 2006; 84: 289-298.
71. Sobngwi E, Mbanya JC, Unwin NC, et al. Physical activity and its relationship with obesity, hypertension and diabetes in urban and rural Cameroon. Int J Obes Relat Metab Disord 2002; 26: 1009-1016.
72. Joubert J, Norman R, Lambert EV, et al. Estimating the burden of disease attributable to physical inactivity in South Africa in 2000. S Afr Med J 2007; 97: 725-731.
73. Puepet FH, Ohwovoriole AE. Prevalence of risk factors for diabetes mellitus in a non-diabetic population in Jos, Nigeria. Niger J Med 2008; 17: 71-74.
74. Townsend L, Flisher AJ, Gilreath T, King G. A systematic literature review of tobacco use among adults 15 years and older in sub-Saharan Africa. Drug Alcohol Depend 2006; 84: 14-27.
75. Monteiro CA, Moura EC, Conde WL, Popkin BM. Socioeconomic status and obesity in adult populations of developing countries: a review. Bull World Health Organ 2004; 82: 940-946.
76. Mendez MA, Monteiro CA, Popkin BM. Overweight exceeds underweight among women in most developing countries. Am J Clin Nutr 2005; 81: 714-721.
77. Ziraba AK, Fotso JC, Ochako R. Overweight and obesity in urban Africa: a problem of the rich or the poor? BMC Public Health 2009; 9: 465.
78. Schneider M, Bradshaw D, Steyn K, Norman R, Laubscher R. Poverty and non-communicable diseases in South Africa. Scand J Public Health 2009; 37: 176-186.
79. Hawkes C. The role of foreign direct investment in the nutrition transition. Public Health Nutr 2005; 8: 357-365.
80. Drewnowski A, Popkin BM. The nutrition transition: new trends in the global diet. Nutr Rev 1997; 55: 31-43.
81. Chen G, Adeyemo A, Zhou J, et al. Genome-wide search for susceptibility genes to type 2 diabetes in West Africans: potential role of C-peptide. Diabetes Res Clin Pract 2007; 78: e1-e6. (Pubitemid 350030984)
82. Young F, Critchley JA, Johnstone LK, Unwin NC. A review of co-morbidity between infectious and chronic disease in sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health 2009; 5: 9.
83. Mugusi F, Swai AB, Alberti KG, McLarty DG. Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle 1990; 71: 271-276.
84. Oluboyo PO, Erasmus RT. The significance of glucose intolerance in pulmonary tuberculosis. Tubercle 1990; 71: 135-138.
85. Coetzee EJ. Pregnancy and diabetes scenario around the world: Africa. Int J Gynaecol Obstet 2009; 104(Suppl 1): S39-S41.
86. Campbell RK. Fate of the beta-cell in the pathophysiology of type 2 diabetes. J Am Pharm Assoc (2003) 2009; 49(Suppl 1): S10-S15.
87. Surampudi PN, John-Kalarickal J, Fonseca VA. Emerging concepts in the pathophysiology of type 2 diabetes mellitus. Mt Sinai J Med 2009; 76: 216-226.
88. Lin Y, Sun Z. Current views on type II diabetes. J Endocrinol 2010; 204: 1-11.
89. Gerich JE. Is insulin resistance the principal cause of type 2 diabetes? Diabetes Obes Metab 1999; 1: 257-263.
90. Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res 2005; 36: 197-209.
91. Kahn SE. Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 4047-4058.
92. Kalk WJ, Joffe BI. The metabolic syndrome, insulin resistance, and its surrogates in African and white subjects with type 2 diabetes in South Africa. Metab Syndr Relat Disord 2008; 6: 247-255.
93. Oli JM, Adeyemo AA, Okafor GO, et al. Basal insulin resistance and secretion in Nigerians with type 2 diabetes mellitus. Metab Syndr Relat Disord 2009; 7: 595-599.
94. Joffe BI, Panz VR, Wing JR, Raal FJ, Seftel HC. Pathogenesis of non-insulin-dependent diabetes mellitus in the black population of southern Africa. Lancet 1992; 340: 460-462.
95. Panz VR, Joffe BI, Wing JR, Raal FJ, Seftel HC. Insulin-receptor activity in nondiabetic and diabetic urbanized South African black women. Diabetes Care 1992; 15: 277-281.
96. Ezenwaka CE, Akanji AO, Osei K, et al. Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1993; 20: 175-181.
97. Amoah AG, Owusu SK, Schuster DP, Osei K. Pathogenic mechanism of type 2 diabetes in Ghanaians - the importance of beta cell secretion, insulin sensitivity and glucose effectiveness. S Afr Med J 2002; 92: 377-384.
98. Osei K, Schuster DP. Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. Diabet Med 1994; 11: 755-762.
99. Osei K, Schuster DP. Effects of race and ethnicity on insulin sensitivity, blood pressure, and heart rate in three ethnic populations: comparative studies in African-Americans, African immigrants (Ghanaians), and white Americans using ambulatory blood pressure monitoring. Am J Hypertens 1996; 9: 1157-1164.
100. Osei K, Schuster DP, Owusu SK, Amoah AG. Race and ethnicity determine serum insulin and C-peptide concentrations and hepatic insulin extraction and insulin clearance: comparative studies of three populations of West African ancestry and white Americans. Metabolism 1997; 46: 53-58.
101. Ferris WF, Naran NH, Crowther NJ, Rheeder P, van der Merwe L, Chetty N. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res 2005; 37: 695-701.
102. Goedecke JH, Levitt NS, Lambert EV, et al. Differential effects of abdominal adipose tissue distribution on insulin sensitivity in black and white South African women. Obesity (Silver Spring) 2009; 17: 1506-1512.
103. Goedecke JH, Dave JA, Faulenbach MV, et al. Insulin response in relation to insulin sensitivity: an appropriate beta-cell response in black South African women. Diabetes Care 2009; 32: 860-865.
104. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924.
105. Osei K, Schuster DP. Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants. Am J Med Sci 1996; 311: 113-121.
106. Shires R, Joffe BI, Seftel HC. Maximal pancreatic beta-cell stimulation and the counter-regulatory hormonal responses in South African black and white obese subjects. S Afr Med J 1985; 67: 845-847.
107. Mbanya JC, Pani LN, Mbanya DN, Sobngwi E, Ngogang J. Reduced insulin secretion in offspring of African type 2 diabetic parents. Diabetes Care 2000; 23: 1761-1765.
108. Amoah AG, Owusu SK, Ayittey OM, Schuster DP, Osei K. Minimal model analyses of beta cell secretion, insulin sensitivity and glucose effectiveness in glucose tolerant, nondiabetic first-degree relatives of Ghanaian patients with type 2 diabetes and healthy control subjects. Ethn Dis 2001; 11: 201-210.
109. der Merwe MT, Panz VR, Crowther NJ, et al. Free fatty acids and insulin levels-relationship to leptin levels and body composition in various patient groups from South Africa. Int J Obes Relat Metab Disord 1999; 23: 909-917.
110. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004; 53(Suppl 3): S16-S21.
111. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-1119.
112. Gnacinska M, Malgorzewicz S, Stojek M, Lysiak-Szydlowska W, Sworczak K. Role of adipokines in complications related to obesity. A review. Adv Med Sci 2009; 54: 150-157.
113. van der Merwe MT, Wing JR, Celgow LH, et al. Metabolic indices in relation to body composition changes during weight loss on dexfenfluramine in obese women from two South African ethnic groups. Int J Obes Relat Metab Disord 1996; 20: 768-776.
114. Buthelezi EP, van der Merwe MT, Lonnroth PN, Gray IP, Crowther NJ. Ethnic differences in the responsiveness of adipocyte lipolytic activity to insulin. Obes Res 2000; 8: 171-178.
115. Sobngwi E, Effoe V, Boudou P, Njamen D, Gautier JF, Mbanya JC. Waist circumference does not predict circulating adiponectin levels in sub-Saharan women. Cardiovasc Diabetol 2007; 6: 31.
116. Schutte AE, Huisman HW, Schutte R, et al. Differences and similarities regarding adiponectin investigated in African and Caucasian women. Eur J Endocrinol 2007; 157: 181-188.
117. Doumatey AP, Lashley KS, Huang H, et al. Relationships among obesity, inflammation, and insulin resistance in African Americans and West Africans. Obesity (Silver Spring) 2010; 18: 598-603.
118. Ntyintyane L, Panz V, Raal FJ, Gill G. Leptin, adiponectin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in urban South African blacks with and without coronary artery disease. Metab Syndr Relat Disord 2009; 7: 243-248.
119. Joshi MD, Wala J, Acharya KS, Amayo A. High-sensitivity Creactive protein in type 2 diabetic patients with and without the metabolic syndrome. East Afr Med J 2008; 85: 178-186.
120. Elnasri HA, Ahmed AM. Patterns of lipid changes among type 2 diabetes patients in Sudan. East Mediterr Health J 2008; 14: 314-324.
121. Mbanya JC, Sobngwi E. Diabetes in Africa. Diabetes microvascular and macrovascular disease in Africa. J Cardiovasc Risk 2003; 10: 97-102.
122. Kalk WJ, Joannou J, Ntsepo S, Mahomed I, Mahanlal P, Becker PJ. Ethnic differences in the clinical and laboratory associations with retinopathy in adult onset diabetes: studies in patients of African, European and Indian origins. J Intern Med 1997; 241: 31-37.
123. Lester FT. Clinical features, complications and mortality in type 2 (non-insulin dependent) diabetic patients in Addis Abeba, Ethiopia, 1976-1990. Ethiop Med J 1993; 31: 109-126.
124. Tumosa N. Eye disease and the older diabetic. Clin Geriatr Med 2008; 24: 515-527, vii.
125. Levitt NS, Bradshaw D, Zwarenstein MF, Bawa AA, Maphumolo S. Audit of public sector primary diabetes care in Cape Town, South Africa: high prevalence of complications, uncontrolled hyperglycaemia, and hypertension. Diabet Med 1997; 14: 1073-1077.
126. Sobngwi E, Mbanya JC, Moukouri EN, Ngu KB. Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res Clin Pract 1999; 44: 191-196.
127. Mash B, Powell D, du Plessis F, Van Vuuren U, Michalowska M, Levitt N. Screening for diabetic retinopathy in primary care with a mobile fundal camera - evaluation of a South African pilot project. S Afr Med J 2007; 97: 1284-1288.
128. Azevedo M. Diabetes in sub-Saharan Africa: Kenya, Mali, Mozambique, Nigeria, South Africa and Zambia. Int J Diab Dev Ctries 2008; 28: 101-108.
129. Mwale C, Karimurio J, Njuguna M. Refractive errors in type 2 diabetic patients. East Afr Med J 2007; 84: 259-263.
130. Sidibe EH. Diabetic retinopathy in Dakar and review of African literature: epidemiologic elements. Diabetes Metab 2000; 26: 322-324.
131. Rahlenbeck SI, Gebre-Yohannes A. Prevalence and epidemiology of micro- and macroalbuminuria in Ethiopian diabetic patients. J Diabetes Complications 1997; 11: 343-349.
132. Drabo PY, Kabore J, Lengani A. Complications of diabetes mellitus at the Hospital Center of Ouagadougou. Bull Soc Pathol Exot 1996; 89: 191-195.
133. Abbas ZG, Archibald LK. Epidemiology of the diabetic foot in Africa. Med Sci Monit 2005; 11: RA262-RA 270.
134. Abbas ZG, Gill GV, Archibald LK. The epidemiology of diabetic limb sepsis: an African perspective. Diabet Med 2002; 19: 895-899.
135. Gill GV, Mbanya JC, Ramaiya KL, Tesfaye S. A sub-Saharan African perspective of diabetes. Diabetologia 2009; 52: 8-16.
136. Seyoum B. Impotence in Ethiopian diabetic men. East Afr Med J 1998; 75: 208-210.
137. Gueye SM, Diop SN, Ba M, et al. Erectile dysfunction in diabetics. Epidemiological profile in Senegal. Prog Urol 1998; 8: 377-381.
138. Elbagir MN, Eltom MA, Mahadi EO, Berne C. Pattern of longterm complications in Sudanese insulin-treated diabetic patients. Diabetes Res Clin Pract 1995; 30: 59-67.
139. Akinboboye O, Idris O, Akinboboye O, Akinkugbe O. Trends in coronary artery disease and associated risk factors in sub-Saharan Africans. J Hum Hypertens 2003; 17: 381-387.
140. Muna WF. Cardiovascular disorders in Africa. World Health Stat Q 1993; 46: 125-133.
141. Kengne AP, Amoah AG, Mbanya JC. Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation 2005; 112: 3592-3601.
142. Steyn K, Sliwa K, Hawken S, et al. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation 2005; 112: 3554-3561. (Pubitemid 43739532)
143. Ntyintyane LM, Panz VR, Raal FJ, Gill GV. Metabolic syndrome, undiagnosed diabetes mellitus and insulin resistance are highly prevalent in urbanised South African blacks with coronary artery disease. Cardiovasc J S Afr 2006; 17: 50-55.
144. Walker RW, McLarty DG, Kitange HM, et al. Stroke mortality in urban and rural Tanzania. Adult Morbidity and Mortality Project. Lancet 2000; 355: 1684-1687.
145. Rolfe M. Macrovascular disease in diabetics in Central Africa. Br Med J (Clin Res Ed) 1988; 296: 1522-1525.
146. Kolawole BA, Ajayi AA. Prognostic indices for intra-hospital mortality in Nigerian diabetic NIDDM patients. Role of gender and hypertension. J Diabetes Complications 2000; 14: 84-89.
147. Elmahdi EM, Kaballo AM, Mukhtar EA. Features of non-insulin-dependent diabetes mellitus (NIDDM) in the Sudan. Diabetes Res Clin Pract 1991; 11: 59-63.
148. Niang EH, Diop SN, Sidibe EA, Badiane M, Lamouche JP, Sow AM. Echographic and velocimetric aspects of arteriopathies in the diabetic. Dakar Med 1994; 39: 37-42.
149. Castle WM, Wicks AC. A follow-up of 93 newly diagnosed African diabetics for 6 years. Diabetologia 1980; 18: 121-123.
150. Lester FT. Long-standing diabetes mellitus in Ethiopia: a survey of 105 patients. Diabetologia 1983; 25: 222-225.
151. Lester FT. Clinical status of Ethiopian diabetic patients after 20 years of diabetes. Diabet Med 1991; 8: 272-276.
152. McLarty DG, Kinabo L, Swai AB. Diabetes in tropical Africa: a prospective study, 1981-7. II. Course and prognosis. BMJ 1990; 300: 1107-1110.
153. Rwiza HT, Swai AB, McLarty DG. Failure to diagnose diabetic ketoacidosis in Tanzania. Diabet Med 1986; 3: 181-183.
154. Rolfe M, Ephraim GG, Lincoln DC, Huddle KR. Hyperosmolar non-ketotic diabetic coma as a cause of emergency hyperglycaemic admission to Baragwanath Hospital. S Afr Med J 1995; 85: 173-176.
155. Mbugua PK, Otieno CF, Kayima JK, Amayo AA, McLigeyo SO. Diabetic ketoacidosis: clinical presentation and precipitating factors at Kenyatta National Hospital, Nairobi. East Afr Med J 2005; 82: S191-S196.
156. Gill GV, Huddle KR. Hypoglycaemic admissions among diabetic patients in Soweto, South Africa. Diabet Med 1993; 10: 181-183.
157. Nambuya AP, Otim MA, Whitehead H, Mulvany D, Kennedy R, Hadden DR. The presentation of newly-diagnosed diabetic patients in Uganda. QJM 1996; 89: 705-711.
158. Balde NM, Camara A, Camara LM, Diallo MM, Kake A, Bah-Sow OY. Associated tuberculosis and diabetes in Conakry, Guinea: prevalence and clinical characteristics. Int J Tuberc Lung Dis 2006; 10: 1036-1040.
159. Gill GV, Famuyiwa OO, Rolfe M, Archibald LK. Tropical diabetic hand syndrome. Lancet 1998; 351: 113-114.
160. Abbas ZG, Lutale J, Gill GV, Archibald LK. Tropical diabetic hand syndrome: risk factors in an adult diabetes population. Int J Infect Dis 2001; 5: 19-23.
161. Naicker S. End-stage renal disease in sub-Saharan and South Africa. Kidney Int Suppl 2003; 83: S119-S122.
162. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
163. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
164. Benhalima K, Mathieu C. Challenges in the management of hyperglycaemia in type 2 diabetes. In International Diabetes Federation. Diabetes Atlas (4th edn). International Diabetes Federation: Brussels, Belgium, 2009.
165. Truter I. An investigation into antidiabetic medication prescribing in South Africa. J Clin Pharm Ther 1998; 23: 417-422.
166. Yusuff KB, Obe O, Joseph BY. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria. Pharm World Sci 2008; 30: 876-883.
167. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32: 193-203.
168. Otieno CF, Huho AN, Omonge EO, Amayo AA, Njagi E. Type 2 diabetes mellitus: clinical and aetiologic types, therapy and quality of glycaemic control of ambulatory patients. East Afr Med J 2008; 85: 24-29.
169. Williams B. The obese hypertensive: the weight of evidence against beta-blockers. Circulation 2007; 115: 1973-1974.
170. Otieno CF, Vaghela V, Mwendwa FW, Kayima JK, Ogola EN. Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi. East Afr Med J 2005; 82: S184-S190.
171. Justin-Temu M, Nondo RS, Wiedenmayer K, Ramaiya KL, Teuscher A. Anti-diabetic drugs in the private and public sector in Dar es Salaam, Tanzania. East Afr Med J 2009; 86: 110-114.
172. Mbanya JC, Mbanya D. Diabetes cost in sub-Saharan Africa. J Cardiovasc Risk 2003; 10: 191-193.
173. Beran D, Yudkin JS. Diabetes care in sub-Saharan Africa. Lancet 2006; 368: 1689-1695.
174. Chale SS, Swai AB, Mujinja PG, McLarty DG. Must diabetes be a fatal disease in Africa? Study of costs of treatment. BMJ 1992; 304: 1215-1218.
175. Peltzer K, Khoza LB, Lekhuleni ME, Madu SN, Cherian VI, Cherian L. Concepts and treatment for diabetes among traditional and faith healers in the northern province, South Africa. Curationis 2001; 24: 42-47.
176. de-Graft Aikins A. Healer shopping in Africa: new evidence from rural-urban qualitative study of Ghanaian diabetes experiences. BMJ 2005; 331: 737.
177. Beran D, Yudkin JS. Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resourcepoor settings. In International Diabetes Federation. Diabetes Atlas (4th ed). International Diabetes Federation: Brussels, Belgium, 2009.
178. Whiting DR, Hayes L, Unwin NC. Diabetes in Africa. Challenges to health care for diabetes in Africa. J Cardiovasc Risk 2003; 10: 103-110.
179. International Diabetes Federation. The Diabetes Declaration and Strategy for Africa: a call to action and plan of action to prevent and control diabetes and related chronic diseases. 2006; http://www.idf.org/webdata/docs/ Diabetes%20Declaration %20&%20Strategy%20for%20Africa full.pdf [9 December 2009].
180. Njamnshi A, Hiag BA, Mbanya JC. From research policy: the development of a national diabetes programme. Diabetes Voice 2006; 51: 18-21.